Event 2021 – Part 6 (ADE, Vaccine Efficacy)
1.) Fleming Documents
2.) Antibody Dependent Enhancement
3.) Do the Vaccines Reduce your Risk of COVID?
4.) What does Vaccine Efficacy Really Mean?
5.) How did they decide covid diagnosis?
6.) Pfizer Vaccine Efficacy (from EUA documents)
7.) If I’ve already been infected, should I get Vaccinated?
Event 2021 Notes (Source)
|01||An infectivity-enhancing site on the SARS-CoV-2 spike protein is targeted by COVID-19 patient antibodies Yafei Liu, Wai Tuck Soh, Asa Tada, Akemi Arakawa, Sumiko Matsuoka, Emi E. Nakayama, Songling Li, Chikako Ono, Shiho Torii, Kazuki Kishida, Hui Jin, Wataru Nakai, Noriko Arase, Atsushi Nakagawa, Yasuhiro Shindo, Masako Kohyama, Hironori Nakagami, Keisuke Tomii, Koichiro Ohmura, Shiro Ohshima, Masato Okada, Yoshiharu Matsuura, Daron M. Standley, Tatsuo Shioda, Hisashi Arase bioRxiv 2020.12.18.423358; doi: https://doi.org/10.1101/2020.12.18.423358|
|02||Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcR Pathway (highlighted)|
|03||ADE shown in animals including primates January 2, 2021|
|04||ADE (Osaka Paper) showing antibodies to NTD increase infectivity of SARS-CoV-2 December 18, 2020|
|05, 06, 07||Event 2021 – Part 6 – Rumble|